Medical Kratom Laws: New Perspective from Thailand
Keywords:
Kratom, laws, Thailand, narcotic, medicalAbstract
Kratom is an important tropical plant that has a possible medical usefulness. However, it can cause addiction in the user and classified as a narcotic. Kraom addiction is accepted as an additive substance disorder. Worldwide, kratom is usually controlled by narcotics drug laws. In the present day, the legalization of medical kratom is a new aspect. In Thailand, the medical kratom laws is launched and become the interesting issue for further discussion. In the present article, the authors discuss on the medical kratom, with special focus on the new perspective from Thailand.
References
1. Eastlack SC, Cornett EM, Kaye AD. Kratom -Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review. Pain Ther. 2020; 9 (1): 55–69p.
2. Swogger MT, Walsh Z. Kratom use and mental health: A systematic review. Drug Alcohol Depend. 2018; 183: 134–140p.
3. Sanderson M, Rowe A. Kratom. CMAJ. 2019; 191(40): E1105p.
4. Warner ML, Kaufman NC, Grundmann O. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. Int J Legal Med. 2016; 130(1):127–38p.
5. Chawla N, Sood M. Medical marijuana laws and marijuana use in the USA: Any lessons ? Natl Med J India. 2016; 29 (4): 220–221p.
6. Mead A. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law. Epilepsy Behav. 2017; 70 (Pt B): 288–291p.
7. Compton WM, Volkow ND, Lopez MF. Medical Marijuana Laws and Cannabis Use: Intersections of Health and Policy. JAMA Psychiatry. 2017; 74 (6): 559–560.
8. Stafford N. Germany considers legalising cannabis for medical use. BMJ. 2015; 351: h5952p.
9. Stafford N. Germany sets up new agency t o oversee production of med icinal cannabis. BMJ. 2017; 356: j706p. Medical Kratom Laws: New Perspective from Thailand Mungmunpuntipantip and Wiwanitkti
10. Mungmunpuntipantip R, Wiwanitkit V. Medical marijuana laws: New perspective from Thailand. Indian J Health Med Law. 2018; 1: 69 – 70p.
11. Prozialeck WC. Update on the Pharmacology and Legal Status of Kratom. J Am Osteopath Assoc. 2016; 116 (12): 802–809p.
12. Goldin D, Salani D, Mckay M. Kratom: Implications for Health Care Providers. J Psychosoc Nurs Ment Health Serv. 2019; 57 (12): 15–20p.
13. Prozialeck WC, Avery BA, Boyer EW, et al . Kratom policy: The challenge of balancing therapeutic potential with public safety. Int J Drug Policy. 2019; 70: 70–77p.
14. Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, Roman -Urrestarazu A. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asi a. Hum Psychopharmacol. 2017; 32(3).
15. Trakulsrichai S, Tongpo A, Sriapha C, et al . Kratom abuse in Ramathibodi Poison Center, Thailand: a five-year experience. J Psychoactive Drugs. 2013; 45 (5): 404–8p.
16. LaBryer L, Sharma R, Chaudhari KS, Talsania M, Scofield RH. Kr atom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report. J Investig Med High Impact Case Rep. 2018; 6: 2324709618765022p.
17. Chang-Chien GC, Odonkor CA, Amorapanth P. Is Kratom the New 'Legal High' on the Block? The Ca se of an Emerging Opioid Receptor Agonist with Substance Abuse Potential. Pain Physician. 2017; 20 (1): E195-E198p.
18. Palasamudram Shekar S, Rojas EE, D'Angelo CC, Gillenwater SR, Martinez Galvis NP. Legally Lethal Kratom: An Herbal Supplement with Overdose Potential. J Psychoactive Drugs. 2019; 51 (1): 28–30p.
